Antifungal resistance represents a critical threat to global healthcare systems. Consequently, medical researchers are exploring innovative ways to treat multidrug-resistant fungal infections. A recent breakthrough involves the use of lignin-capped silver nanoparticles (OL/Ag/AgCl-NPs). These particles demonstrate exceptional efficacy against pathogens that standard drugs like Amphotericin B cannot stop.

The synthesis of these nanoparticles follows a fast, green photochemical method. Specifically, the process uses organosolv lignin to cap silver/silver chloride nanoparticles. This approach creates a unique three-layered architecture. It consists of a silver chloride core, a metallic silver surface, and a thin protective lignin layer. Furthermore, this method is sustainable and reduces the need for toxic chemicals.

Efficacy of Lignin-capped Silver Nanoparticles

The study evaluated the performance of these nanoparticles against several Candida species. Notably, the researchers found that Candida tropicalis exhibited high resistance to Amphotericin B. However, the lignin-capped silver nanoparticles showed remarkable activity against this resistant strain. In fact, the nanoparticles achieved a fungicidal effect, effectively killing the resistant cells at low concentrations.

Additionally, the research examined the impact of these particles on human VERO cells. Although high doses showed some toxicity, the cells recovered their metabolic activity over time. Therefore, the cytotoxic effects might be reversible. This finding is encouraging for future biomedical applications. These nanoparticles could provide a versatile platform for developing safe and effective antifungal therapies in clinical settings.

Frequently Asked Questions

How do these nanoparticles overcome fungal resistance?

The nanoparticles utilize multiple mechanisms, including membrane disruption and the release of silver ions. The lignin coating improves stability and biocompatibility. Consequently, the particles can penetrate resistant fungal walls more effectively than traditional polyene antibiotics.

What is the benefit of using organosolv lignin in synthesis?

Organosolv lignin acts as a natural capping agent that enhances the sustainability of the process. In addition, it provides a biocompatible outer layer. This reduces environmental impact and improves the interaction between the nanoparticle and biological cells.

Can these nanoparticles be used for other fungal infections?

Yes. The study demonstrated broad-spectrum activity against various pathogens, including Nakaseomyces glabratus and Pichia kudriavzevii. Researchers believe these materials could form a broad platform for treating many types of resistant fungal infections.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Fernandes DGDS et al. Fungicidal efficacy of green-synthesized organosolv lignin-capped silver-based nanoparticles against amphotericin B-resistant Candida tropicalis. Folia Microbiol (Praha). 2026 Feb 21. doi: 10.1007/s12223-026-01432-2. PMID: 41722017.

Marulasiddeshwara MB et al. Facile-one pot-green synthesis, antibacterial, antifungal, antioxidant and antiplatelet activities of lignin capped silver nanoparticles: A promising therapeutic agent. Mater Sci Eng C Mater Biol Appl. 2017 Dec 1;81:182-190. doi: 10.1016/j.msec.2017.07.039. PMID: 28887963.

Galkina S et al. Preparation and Biological Activity of Lignin–Silver Hybrid Nanoparticles. ACS Omega. 2024 Nov 19;9(46):47255–47266. doi: 10.1021/acsomega.4c06637.